Home

Passif propriétaire Tordu sanofi regeneron alliance Inhaler Cligner montant des ventes

Brevets: pourquoi plusieurs laboratoires se mêlent de la guerre entre Sanofi  et Amgen
Brevets: pourquoi plusieurs laboratoires se mêlent de la guerre entre Sanofi et Amgen

Successful Partnership Between Sanofi and Regeneron - YouTube
Successful Partnership Between Sanofi and Regeneron - YouTube

Emmanuel Barbarin - Head of Sanofi-Regeneron alliance controlling for Sanofi  Industrial Affairs - Sanofi | LinkedIn
Emmanuel Barbarin - Head of Sanofi-Regeneron alliance controlling for Sanofi Industrial Affairs - Sanofi | LinkedIn

Regeneron Sanofi Genzyme Alliance | CE Advocate Aurora Health
Regeneron Sanofi Genzyme Alliance | CE Advocate Aurora Health

Industry Participation | ESMO
Industry Participation | ESMO

Meet Our National Sponsors: AbbVie, maker of HUMIRA & The Sanofi and Regeneron  alliance.
Meet Our National Sponsors: AbbVie, maker of HUMIRA & The Sanofi and Regeneron alliance.

Sanofi, Regeneron to restructure antibody alliance for Kevzara, Praluent
Sanofi, Regeneron to restructure antibody alliance for Kevzara, Praluent

Sanofi revoit son alliance avec Regeneron et doit lui verser 462 millions  de dollars | Le Revenu
Sanofi revoit son alliance avec Regeneron et doit lui verser 462 millions de dollars | Le Revenu

Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Health
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Health

Sanofi et Regeneron révisent leur partenariat
Sanofi et Regeneron révisent leur partenariat

Sanofi a mis en place une stratégie pour accélérer sa croissance -  Capital.fr
Sanofi a mis en place une stratégie pour accélérer sa croissance - Capital.fr

Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters

Sanofi pays Regeneron $462M to exit immuno-oncology R&D pact | Fierce  Biotech
Sanofi pays Regeneron $462M to exit immuno-oncology R&D pact | Fierce Biotech

Sanofi sheds Regeneron stake, but insists collaboration is unaffected |  pharmaphorum
Sanofi sheds Regeneron stake, but insists collaboration is unaffected | pharmaphorum

Sanofi and Regeneron enlist Broadway actor for lung health med
Sanofi and Regeneron enlist Broadway actor for lung health med

Emmanuel Barbarin - Head of Sanofi-Regeneron alliance controlling for Sanofi  Industrial Affairs - Sanofi | LinkedIn
Emmanuel Barbarin - Head of Sanofi-Regeneron alliance controlling for Sanofi Industrial Affairs - Sanofi | LinkedIn

Jeu des chaises musicales entre Sanofi, Alnylam et Regeneron
Jeu des chaises musicales entre Sanofi, Alnylam et Regeneron

Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters

Sanofi, Regeneron Restructure Immuno-Onco Alliance | Contract Pharma
Sanofi, Regeneron Restructure Immuno-Onco Alliance | Contract Pharma

Sanofi plans to unload a $13B Regeneron stake. Is a rare disease buyout  next? | Fierce Pharma
Sanofi plans to unload a $13B Regeneron stake. Is a rare disease buyout next? | Fierce Pharma

Sanofi veut faire du Dupixent un médicament à 10 milliards de dollars | Les  Echos
Sanofi veut faire du Dupixent un médicament à 10 milliards de dollars | Les Echos

Regeneron's Sanofi deal finally turns a profit, thanks to Dupixent | Fierce  Pharma
Regeneron's Sanofi deal finally turns a profit, thanks to Dupixent | Fierce Pharma

Sanofi, Regeneron set Kevzara up for tough rheumatoid arthritis turf battle  with $39K list price | Fierce Pharma
Sanofi, Regeneron set Kevzara up for tough rheumatoid arthritis turf battle with $39K list price | Fierce Pharma

Nous sommes en passe de devenir leader dans le domaine des immunosciences -  Sanofi
Nous sommes en passe de devenir leader dans le domaine des immunosciences - Sanofi

REGENERON restructure l'accord de collaboration avec SANOFI - Capital.fr
REGENERON restructure l'accord de collaboration avec SANOFI - Capital.fr

Pharmacy: Sanofi announces the sale of its share in Regeneron - NEWSTARS  Education
Pharmacy: Sanofi announces the sale of its share in Regeneron - NEWSTARS Education